Studying side effects of lymph node removal in lung cancer surgery
Part of Blood & lymphatic, Cancer, Lungs & breathing clinical trials.
This trial looks at complications from removing lymph nodes during surgery for non-small cell lung cancer. It may help doctors understand how to make surgery safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have non-small cell lung cancer at an early to advanced stage (stage IA to IIIB).
- Your planned surgery will remove a section or all of a lung and include removal of lymph nodes around the windpipe.
- You agree to take part in the study and sign a consent form.
- You cannot have small cell lung cancer, benign tumors, or tumors that started elsewhere.
- You cannot have a minor wedge surgery that leaves lymph nodes in place.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This study looks at whether removing lymph nodes from the opposite side of the chest during surgery can help people with advanced lung cancer that has spread to the lymph nodes in the middle of the chest. It may offer a more thorough treatment for patients who are healthy enough for surgery.
This study looks at certain lymph nodes removed during surgery for non-small cell lung cancer (NSCLC) that has grown into the covering of the lung. The goal is to better understand lymph node involvement and help guide future treatment decisions.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This study compares two surgical approaches for removing lymph nodes in the chest after you've completed chemotherapy and immunotherapy for non-small cell lung cancer. The goal is to determine which approach works best while keeping you as safe as possible.
This trial studies a better way to remove and examine lymph nodes from lung cancer surgery specimens. It aims to improve how doctors check for cancer spread, which may help guide your treatment after surgery.
Hear when a new Lymph Node Dissection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.